|
|
Line 45: |
Line 45: |
| <tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> About our modeling</font></span></h1></td></tr> | | <tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> About our modeling</font></span></h1></td></tr> |
| <tr><td><h1><span style="font-family:Calibri;text-align:left;"><font size="5"> | | <tr><td><h1><span style="font-family:Calibri;text-align:left;"><font size="5"> |
− | To increase efficiency in isolating our AMPs, we introduced a signal peptide upstream of the N-terminal of mature antimicrobial peptides. This signal peptide is obtained from chitinase C of S.lividans (MGFRHKAAALAATLALPLAGLVGLASPAQA). When the premature peptides enter the periplasmic space, peptidase will identify the cleavage site Ala-Gln-Ala and cut at the double Ala between the signal and mature peptide. </br></br>
| + | |
− | To ensure and verify this process, we have attached an Ala at the N-terminal of AMPs. When applying a protein secondary structure prediction software base on the known peptide structure, we can analyze whether the attached Ala may have an effect on the peptide folding process.
| + | |
| </br></br> | | </br></br> |
| </font></span></h1></td> | | </font></span></h1></td> |
Line 57: |
Line 56: |
| <div class="inner"> | | <div class="inner"> |
| <table width="95%" align="center"> | | <table width="95%" align="center"> |
− | <tr><td align="left"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> Signiferin peptide structure analysis</font></span></h1></td></tr> | + | <tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="6"><font-weight: 700;>Macro Dilution</font></span></h1></td></tr> |
− | <tr>
| + | |
− | <td width="90%" align="center"><img src="https://static.igem.org/mediawiki/2015/e/ee/2015tcutaiwanModelingwithoutA1.jpg" align=center width="80%" title="Result 1"></td>
| + | |
− | </tr>
| + | |
| </table> | | </table> |
| </div> | | </div> |
| </div> | | </div> |
| + | |
| | | |
| <div id="st1" class="st"> | | <div id="st1" class="st"> |
| <div class="inner"> | | <div class="inner"> |
| <table width="95%" align="center"> | | <table width="95%" align="center"> |
− | | + | <tr> |
− | <td width="45%" align="center"><img src="https://static.igem.org/mediawiki/2015/f/f8/2015tcutaiwanModelingwithA1.jpg" align=center width="80%" title="Result 1"></td> | + | <td width="90%" align="center"><img src="https://static.igem.org/mediawiki/2015/a/a7/2015tcutaiwanThe_peptides_efficiency_of_disinfection.JPG" align=center width="60%" title="Result 1"></td> |
| </tr> | | </tr> |
− | </table> | + | <tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br> |
− | </div> | + | |
− | </div> | + | |
| | | |
− | <div id="st1" class="st">
| |
− | <div class="inner">
| |
− | <table width="95%" align="center">
| |
− | <tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br>
| |
− | The first column shows the amino acid sequence that we predict.
| |
− | The second column shows that AMPs corresponding secondary structure state are still a-helix.
| |
− | The third column shows the probability of correct prediction.
| |
| </br></br> | | </br></br> |
− | </font></span></h1></td></tr> | + | </font></span></h1></td></tr> |
| </table> | | </table> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
− | <div id="st1" class="st">
| |
− | <div class="inner">
| |
− | <table width="95%" align="center">
| |
− | <tr>
| |
− | <tr><td align="left"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> Epinicedin-1 pepetide structure analysis</font></span></h1></td></tr>
| |
− | <tr>
| |
− | <td width="45%" align="center"><img src="https://static.igem.org/mediawiki/2015/8/82/2015tcutaiwanModelingepi-1withoutA1.jpg" align=center width="80%" title="Result 4"></td>
| |
− | </tr>
| |
− | </table>
| |
− | </div>
| |
− | </div>
| |
| | | |
| <div id="st1" class="st"> | | <div id="st1" class="st"> |
| <div class="inner"> | | <div class="inner"> |
| <table width="95%" align="center"> | | <table width="95%" align="center"> |
− | <tr>
| + | <tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="6"><font-weight: 700;> Cell </font></span></h1></td></tr> |
− | <td width="90%" align="center"><img src="https://static.igem.org/mediawiki/2015/1/10/2015tcutaiwanigemModelingepi-1withA1.jpg" align=center width="80%" title="Result 3"></td> | + | |
− |
| + | |
− | </tr>
| + | |
| </table> | | </table> |
| </div> | | </div> |
| </div> | | </div> |
| | | |
− | <div id="st1" class="st">
| |
− | <div class="inner">
| |
− | <table width="95%" align="center">
| |
− | <tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br>
| |
− | The first column shows the amino acid sequence that we predict.
| |
− | The second column shows that AMPs corresponding secondary structure state are still a-helix.
| |
− | The third column shows the probability of correct prediction.
| |
− | </br></br>
| |
− | </font></span></h1></td></tr>
| |
− | </table>
| |
− | </div>
| |
− | </div>
| |
| | | |
| | | |
− | <div id="st1" class="st">
| |
− | <div class="inner">
| |
− | <table width="95%" align="center">
| |
| | | |
− | <tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> Conclusion</font></span></h1></td></tr>
| + | |
− | <tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br>
| + | |
− | Through the analysis of the peptide secondary structure and confirmation of the -helix structure, the results show whether Ala is attached to Signiferin or Epinecidin-1, the peptide did not affect the peptide folding process. process.
| + | |
− | </br></br>
| + | |
− | </font></span></h1></td></tr>
| + | |
− | </table>
| + | |
− | </div>
| + | |
− | </div>
| + | |
| </body> | | </body> |
| </html> | | </html> |
| {{TCU_Taiwan/CSSfooter}} | | {{TCU_Taiwan/CSSfooter}} |